REG - Bank of Nova Scotia - Publication of a Supplementary Prospectus

Bank of Nova ScotiaAnnouncement

Thu 12:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251211:nRSK2355La&default-theme=true

RNS Number : 2355L  Bank of Nova Scotia  11 December 2025

Regulatory Announcement

 

 

RNS Number: 2355L

The Bank of Nova Scotia

11 December 2025

 

Publication of Prospectus Supplement

 

Not for release, publication or distribution, directly or indirectly, in or
into the United States.

 

The following supplement has been approved by the Financial Conduct Authority
and is available for viewing:

 

Second Supplement dated 11 December 2025 relating to the U.S.$40,000,000,000
Euro Medium Term Note Programme of The Bank of Nova Scotia.

 

The Second Supplement, together with the documents incorporated by reference
therein, have been submitted to the National Storage Mechanism and will
shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus dated 8 July
2025, as supplemented by the First Supplement dated 26 August 2025 and the
Second Supplement dated 11 December 2025 (together, the "Prospectus"), may be
addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries and/or to whom
the offer contained in the Prospectus is not addressed.  Prior to relying on
the information contained in the Prospectus you must ascertain from the
Prospectus whether or not you are part of the intended addressees of the
information contained therein.

 

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") or the securities
laws of any state of the US and are subject to US tax law requirements.
Subject to certain exceptions, the Notes may not be offered, sold or
delivered, directly or indirectly, in or into the US or to or for the account
or benefit of a "US person" (as defined in Regulation S under the Securities
Act).  No public offering of the Notes is being made in the US.  This
announcement does not constitute an offer to sell or a solicitation to buy
securities in the US or in any other jurisdiction where such offer or
solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above
requirement.

 

To view the full document, please paste the following URL into the address bar
of your browser.

 

Second Supplement dated 11 December 2025

(http://www.rns-pdf.londonstockexchange.com/rns/%E2%97%8F)
http://www.rns-pdf.londonstockexchange.com/rns/2355L_1-2025-12-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2355L_1-2025-12-11.pdf)

 

Documents Incorporated by Reference (or certain portions thereof as specified
under "Documents Incorporated by Reference" in the Prospectus):

 

BNS Annual Information Form dated 2 December 2025

http://www.rns-pdf.londonstockexchange.com/rns/2355L_2-2025-12-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2355L_2-2025-12-11.pdf)

 

BNS 2025 Annual Report

http://www.rns-pdf.londonstockexchange.com/rns/2355L_3-2025-12-11.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/2355L_3-2025-12-11.pdf)

 

 

 

For further information, please contact:

 

The Bank of Nova Scotia

40 Temperance Street

Toronto, Ontario

Canada M5H 0B4

 

Attn: Managing Director, Term Funding & Capital Management

Tel.: 001 416 860 1784

Fax: 001 416 945 4001

 

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPTBBTTMTJBBMA



            Copyright 2019 Regulatory News Service, all rights reserved